• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年美国花粉热的花费。

Costs of hay fever in the United States in 1990.

作者信息

McMenamin P

机构信息

Battelle Medical Technology Assessment and Policy Research Center, Washington, DC.

出版信息

Ann Allergy. 1994 Jul;73(1):35-9.

PMID:8030800
Abstract

Hay fever, or allergic rhinitis, affects a significant proportion of the US population. The current analysis focuses on the question of estimating both the direct and indirect costs of hay fever in the US for 1990. The basic data used for this analysis derive from continuing national probability surveys of 1) the US civilian noninstitutionalized population and 2) patient visits to offices of nonfederal practicing physicians who are not in hospital-based specialties. The analysis is based on current methods of estimating the costs of illness. The two major components of the estimates are the direct costs of physician visits, diagnostic tests, and medications; and the indirect costs associated with work absences or other reduced productivity for those employed both in and outside the home. For the most part where data were unavailable or potentially unreliable, cost estimates were not imputed. As a result, these estimates should be considered to be biased downward. In spite of these relatively conservative assumptions, the estimates of annual illness costs for 1990 totalled $1.8 billion.

摘要

花粉热,即变应性鼻炎,影响着相当一部分美国人口。当前的分析聚焦于估算1990年美国花粉热的直接成本和间接成本这一问题。用于该分析的基础数据源自持续进行的全国概率调查,调查对象一是美国非机构化平民人口,二是到非联邦执业医师(非医院专科医师)办公室就诊的患者。该分析基于当前估算疾病成本的方法。估算的两大主要组成部分是看医生、诊断测试和药物的直接成本;以及与在家内外工作的人缺勤或其他生产力下降相关的间接成本。在大多数数据不可用或可能不可靠的情况下,未估算成本。因此,这些估算结果应被视为向下偏差。尽管有这些相对保守的假设,但1990年年度疾病成本估算总计达18亿美元。

相似文献

1
Costs of hay fever in the United States in 1990.1990年美国花粉热的花费。
Ann Allergy. 1994 Jul;73(1):35-9.
2
Costs of illness: United States, 1980.疾病成本:美国,1980年。
Natl Med Care Util Expend Surv C. 1986 Apr(3):1-90.
3
The cost of productivity losses associated with allergic rhinitis.与过敏性鼻炎相关的生产力损失成本。
Am J Manag Care. 2000 Mar;6(3):373-8.
4
Incidence, utilization, and costs associated with acute respiratory conditions, United States, 1980.1980年美国急性呼吸道疾病的发病率、利用率及相关费用
Natl Med Care Util Expend Surv C. 1986 Sep(4):1-63.
5
Economic costs of diabetes in the U.S. In 2007.2007年美国糖尿病的经济成本。
Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017.
6
The annual impact of seasonal influenza in the US: measuring disease burden and costs.美国季节性流感的年度影响:衡量疾病负担和成本。
Vaccine. 2007 Jun 28;25(27):5086-96. doi: 10.1016/j.vaccine.2007.03.046. Epub 2007 Apr 20.
7
Costs of nine common mental disorders: implications for curative and preventive psychiatry.九种常见精神障碍的成本:对治疗性和预防性精神病学的启示
J Ment Health Policy Econ. 2006 Dec;9(4):193-200.
8
Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.第一代抗组胺药治疗变应性鼻炎的成本效益分析。
Pharmacoeconomics. 2004;22(14):929-42. doi: 10.2165/00019053-200422140-00003.
9
Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.第二代抗组胺药转换为非处方药状态的成本效益分析。
Med Care. 2003 Dec;41(12):1382-95. doi: 10.1097/01.MLR.0000100584.18276.C4.
10
National Ambulatory Medical Care Survey: 2001 summary.国家门诊医疗护理调查:2001年总结
Adv Data. 2003 Aug 11(337):1-44.

引用本文的文献

1
Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis.巴西儿童过敏性结膜炎监测和治疗指南。
Arq Bras Oftalmol. 2021 Nov 29;85(4):415-425. doi: 10.5935/0004-2749.20220053. eCollection 2021.
2
Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis.孟鲁司特对过敏性鼻炎症状严重程度评分的影响。
Cureus. 2020 Mar 25;12(3):e7403. doi: 10.7759/cureus.7403.
3
TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study.TOTALL:变应性鼻炎的高成本-一项基于瑞典全国人群的问卷调查研究。
NPJ Prim Care Respir Med. 2016 Feb 4;26:15082. doi: 10.1038/npjpcrm.2015.82.
4
Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey.患者对糠酸莫米松鼻喷雾剂态度的评估:使用方便性患者调查。
World Allergy Organ J. 2008 Sep;1(9):156-9. doi: 10.1097/WOX.0b013e3181865f99.
5
Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.变应性鼻炎的持续低度炎症:对当前治疗策略的影响。
Clin Exp Immunol. 2009 Dec;158(3):260-71. doi: 10.1111/j.1365-2249.2009.04017.x. Epub 2009 Aug 25.
6
Montelukast in the management of allergic rhinitis.孟鲁司特在变应性鼻炎治疗中的应用。
Ther Clin Risk Manag. 2007 Jun;3(2):327-32. doi: 10.2147/tcrm.2007.3.2.327.
7
Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.第一代抗组胺药治疗变应性鼻炎的成本效益分析。
Pharmacoeconomics. 2004;22(14):929-42. doi: 10.2165/00019053-200422140-00003.
8
Allergic rhinitis in children : diagnosis and management strategies.儿童过敏性鼻炎:诊断与管理策略
Paediatr Drugs. 2004;6(4):233-50. doi: 10.2165/00148581-200406040-00003.
9
The economic burden of allergic rhinitis: a critical evaluation of the literature.过敏性鼻炎的经济负担:文献的批判性评估
Pharmacoeconomics. 2004;22(6):345-61. doi: 10.2165/00019053-200422060-00002.
10
The cost of treating allergic rhinitis.过敏性鼻炎的治疗费用。
Curr Allergy Asthma Rep. 2002 May;2(3):223-30. doi: 10.1007/s11882-002-0023-0.